Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Zhejiang Hisun Biomaterials Co's PEG Ratio or its related term are showing as below:
SHSE:688203'
s PEG Ratio Range Over the Past 10 Years
Min: 1.84 Med: 2.79 Max: 2281.54
Current: 1594.8
During the past 8 years, Zhejiang Hisun Biomaterials Co's highest PEG Ratio was 2281.54. The lowest was 1.84. And the median was 2.79.
SHSE:688203's PEG Ratio is ranked worse than 99.67% of 611
companies
in the Chemicals industry
Industry Median: 2.11
vs SHSE:688203: 1594.80
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Zhejiang Hisun Biomaterials Co (SHSE:688203) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Zhejiang Hisun Biomaterials Co PEG Ratio Related Terms
Zhejiang Hisun Biomaterials Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Zhejiang Hisun Biomaterials Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Hisun Biomaterials Co PEG Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Zhejiang Hisun Biomaterials Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Zhejiang Hisun Biomaterials Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Zhejiang Hisun Biomaterials Co (SHSE:688203) has a PEG Ratio of 1,594.83 as of Jul. 19, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Zhejiang Hisun Biomaterials Co and its competitors. This is 57062% above median its historical median of 2.79. Over the past decade, Zhejiang Hisun Biomaterials Co's PEG Ratio has ranged from 1.84 to 2,281.54. According to the industry distribution chart, Zhejiang Hisun Biomaterials Co ranks #609 out of 611 companies in the Chemicals industry, placing it in the top 99.7%.
Is Zhejiang Hisun Biomaterials Co's PEG Ratio too high?
Zhejiang Hisun Biomaterials Co's current PEG Ratio of 1,594.83 is 57062% above median its 10-year median of 2.79. Over the past 10 years, this metric has ranged from a low of 1.84 to a high of 2,281.54. The Chemicals industry median PEG Ratio is 2.11. Zhejiang Hisun Biomaterials Co's value of 1,594.83 is 75484.4% above this industry median. Based on the distribution chart, Zhejiang Hisun Biomaterials Co ranks #609 out of 611 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Zhejiang Hisun Biomaterials Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisun Biomaterials Co's PEG Ratio compare to DOW?
According to the Chemicals industry distribution chart, Zhejiang Hisun Biomaterials Co ranks #609 out of 611 companies for PEG Ratio. This places Zhejiang Hisun Biomaterials Co in the lower half of its industry. The industry median PEG Ratio is 2.11. Zhejiang Hisun Biomaterials Co's value of 1,594.83 is 75484.4% above this benchmark. Historically, Zhejiang Hisun Biomaterials Co's own PEG Ratio has ranged from 1.84 to 2,281.54 over the past decade. While the company's 10-year median is 2.79 vs. the industry median of 2.11, Zhejiang Hisun Biomaterials Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Chemicals company?
The median PEG Ratio among Chemicals companies is 2.11, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Hisun Biomaterials Co's current PEG Ratio of 1,594.83 is 75484.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Zhejiang Hisun Biomaterials Co and its competitors. For the Chemicals industry, the median PEG Ratio is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Hisun Biomaterials Co's current PEG Ratio is 1,594.83, which is 57062% above median its own 10-year median of 2.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisun Biomaterials Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Hisun Biomaterials Co (SHSE:688203) is currently considered Possible Value Trap. The stock's GF Value™ is ¥13.95, compared to a current price of ¥9.25 — trading 33.7% below its estimated fair value. The current PEG Ratio is 1,594.83, which is 57062% above median its 10-year median of 2.79 and 75484.4% above the Chemicals industry median of 2.11. Zhejiang Hisun Biomaterials Co's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Zhejiang Hisun Biomaterials Co (SHSE:688203), the current PEG Ratio is 1,594.83 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Hisun Biomaterials Co (SHSE:688203) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Hisun Biomaterials Co stock appears to be undervalued.
The current stock price of ¥9.25 is trading 33.7% below its estimated GF Value™ of ¥13.95.
GuruFocus considers Zhejiang Hisun Biomaterials Co to be Possible Value Trap.
Key valuation signals for SHSE:688203:
PEG Ratio: 1,594.83 (57062% above median its 10-year median of 2.79)
GF Value™: ¥13.95 vs. price of ¥9.25 (33.7% below fair value)
Industry Position: 75484.4% above the Chemicals median (#609 of 611)
No single metric tells the full story. See the SHSE:688203 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Hisun Biomaterials Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688203 has been successfully added to your 
